Xiao-mei Lu

State Key Laboratory Of Pathogenesis
Ueruemqi, 830011, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

PSD3 links autophagic flux to MHC-I-associated immune modulation in esophageal squamous cell carcinoma.

PSD3 links autophagic flux to MHC-I-associated immune modulation in esophageal squamous cell carcinoma.

Journal: Apoptosis : an international journal on programmed cell death

Published: February 08, 2026

MRPL13 sustains mitochondrial integrity and MAPK-associated aggressiveness in esophageal squamous cell carcinoma.

MRPL13 sustains mitochondrial integrity and MAPK-associated aggressiveness in esophageal squamous cell carcinoma.

Journal: Cancer cell international

Published: December 08, 2025

The untold story of CD82: Exploring its non-canonical roles in cancer.

The untold story of CD82: Exploring its non-canonical roles in cancer.

Journal: Pathology, research and practice

Published: February 23, 2025

Immune cell infiltration and drug sensitivity in PIK3CA-mutated esophageal squamous cell carcinoma: A TCGA database analysis.

Immune cell infiltration and drug sensitivity in PIK3CA-mutated esophageal squamous cell carcinoma: A TCGA database analysis.

Journal: Human immunology

Published: July 25, 2024

Vimentin, inversely correlating with infiltration of CD8 + T lymphocytes, promotes nuclear translocation of PD-L1 in esophageal squamous cell carcinoma.

Vimentin, inversely correlating with infiltration of CD8 + T lymphocytes, promotes nuclear translocation of PD-L1 in esophageal squamous cell carcinoma.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: March 04, 2024

Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example.

Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example.

Journal: Molecular biomedicine

Published: October 25, 2023

miR-133b Promotes Esophageal Squamous Cell Carcinoma Metastasis.

miR-133b Promotes Esophageal Squamous Cell Carcinoma Metastasis.

Journal: Clinical Medicine Insights. Oncology

Published: August 27, 2023

Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer.

Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer.

Journal: Digestive diseases and sciences

Published: August 19, 2023

Promotion of Lung Cancer Metastasis by SIRT2-Mediated Extracellular Protein Deacetylation.

Promotion of Lung Cancer Metastasis by SIRT2-Mediated Extracellular Protein Deacetylation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 20, 2022

Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma.

Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma.

Journal: Journal of proteomics

Published: December 23, 2021

Acetylation licenses Th1 cell polarization to constrain Listeria monocytogenes infection.

Acetylation licenses Th1 cell polarization to constrain Listeria monocytogenes infection.

Journal: Cell death and differentiation

Published: November 09, 2021

KIAA1377 is associated with lymph node metastasis in esophageal squamous cell carcinoma.

KIAA1377 is associated with lymph node metastasis in esophageal squamous cell carcinoma.

Journal: Oncology letters

Published: July 02, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026